Eldred Rock Partners’s Novo Nordisk NVO Stock Holding History

Eldred Rock Partners’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.85M	Sell	163,661 -189	-0.1%	-$8.12K	1.69%	27
2026 Q1	$6.02M	Sell	163,850 -1,440	-0.9%	-$68.2K	1.53%	29
2025 Q4	$8.41M	Sell	165,290 -18,861	-10%	-$964K	2.18%	28
2025 Q3	$10.2M	Buy	184,151 +18,932	+11%	+$1.11M	2.55%	22
2025 Q2	$11.4M	Buy	165,219 +69,184	+72%	+$4.71M	3.47%	13
2025 Q1	$8.81M	Buy	96,035 +20,184	+27%	+$1.67M	2.69%	24
2024 Q4	$6.87M	Sell	75,851 -15,323	-17%	-$1.66M	2.36%	24
2024 Q3	$10.9M	Buy	91,174 +49,484	+119%	+$6.6M	3.63%	13
2024 Q2	$5.95M	Buy	41,690 +10,720	+35%	+$1.42M	2.49%	20
2024 Q1	$3.98M	Sell	30,970 -2,683	-8%	-$319K	2.17%	18
2023 Q4	$3.48M	Buy	+33,653	New	+$3.33M	2.22%	17

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Eldred Rock Partners's NVO Position: Q2 2026 in Review

Eldred Rock Partners reduced its Novo Nordisk (NVO) stake by 0.12% in Q2 2026, selling an estimated $8.12K and leaving 163,661 shares worth $7.85M. The position accounts for 1.69% of the portfolio, ranked #27.

Eldred Rock Partners first reported a position in NVO in Q4 2023 and has held it in 11 quarters since. The position peaked at $11.4M in Q2 2025. 1,346 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Eldred Rock Partners held 163,661 shares of Novo Nordisk worth $7.85M as of Q2 2026.
Eldred Rock Partners sold 189 Novo Nordisk shares in Q2 2026, an estimated $8.12K.
Novo Nordisk made up 1.69% of Eldred Rock Partners's portfolio in Q2 2026, its #27 holding.
Eldred Rock Partners first reported a position in Novo Nordisk in Q4 2023 and has held it in 11 quarters since.
Eldred Rock Partners's Novo Nordisk position peaked at $11.4M in Q2 2025.
1,346 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Eldred Rock Partners's 13F filing for Q2 2026, filed 8 Jul 2026.